IOGEN LLC has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in Taiwan, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and environmental technology are NATRACINE UK LTD, NTD LABS S L and IC MEDTECH CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 2 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Kessler Jack | 10 |
#2 | Litzinger David C | 8 |
#3 | Cerro Andrew M | 8 |
#4 | Rhodes Christopher | 7 |
#5 | Jack Kessler | 1 |
#6 | Christopher Rhodes | 1 |
#7 | Rhodes Christopher A | 1 |
#8 | David C Litzinger | 1 |
#9 | Andrew M Cerro | 1 |
#10 | Kessler Jack Howard | 1 |
Publication | Filing date | Title |
---|---|---|
TW201813648A | Oral molecular iodine composition and method | |
CA3031447A1 | Emollient topical disinfectants | |
US2013039997A1 | Methods for inhibiting the activation of immune cells |